Back to results
US 10,207,027 B2Granted
Bioactive bone graft substitutes
AssigneeGlobus Medical, Inc.
InventorsJevon Nyemscek, Vipin Kunjachan, Allison Adams
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeGlobus Medical, Inc.
InventorsJevon Nyemscek, Vipin Kunjachan, Allison Adams
Estimating the term…
Provided are synthetic bone graft substitutes that include bioactive glass and a carrier. Synthetic bone graft substitutes may include bioactive glass, glycerol and polyethylene glycol. Also provided are bone graft substitutes that include collagen and bioactive glass particles. Example bone graft substitutes may include collagen and bioactive glass particles. Other example embodiments may include Type I Bovine Collagen, an angiogenic agent, such as hyaluronic acid, and bioactive glass. Further provided are methods that include administering the present bone graft substitutes to a mammal, e.g., by surgical insertion of the bone graft substitute into the mammal, either alone or in conjunction with one or more implant devices. Further provided are kits that include the present bone grafts.
A bone graft substitute comprising:
A bone graft substitute consisting of a mixture of 17-20% by weight of type I bovine collagen, 1-5% by weight of hyaluronic acid, and 84% by weight of bioactive glass particles, wherein the bone graft substitute is configured to be implanted into a mammal to provide osteostimulative properties for bone formation,
A bone graft substitute for promoting bone formation, the bone graft substitute consisting of a mixture of a carrier and bioactive glass particles,
Dependencies are inferred from the claim text.